Home › Stocks › INDV › All Fund Holders
INDV — INDIVIOR PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 46 · Reported value held: $2.19B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 18.71M | $767.65M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 5.47M | $196.40M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 3.40M | $139.33M | 0.01% | Reduce |
| Franklin Resources history | Q2 2026 | 3.32M | $136.07M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 3.16M | $129.68M | 0.01% | Add |
| Millennium Management history | Q2 2026 | 2.10M | $86.12M | 0.03% | Reduce |
| Invesco Ltd history | Q2 2026 | 1.84M | $75.62M | 0.01% | Add |
| Arrowstreet Capital history | Q2 2026 | 1.64M | $67.37M | 0.03% | Reduce |
| Point72 Asset Management history | Q2 2026 | 1.25M | $51.31M | 0.20% | Add |
| Northern Trust Corp history | Q2 2026 | 1.24M | $50.95M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.22M | $50.25M | 0.01% | Add |
| Soros Fund Management history | Q4 2025 | 1.15M | $41.42M | 0.54% | Reduce |
| Norges Bank Investment Management history | Q2 2024 | 2.34M | $36.69M | 0.01% | Reduce |
| Principal Global Investors history | Q2 2026 | 772.17K | $31.68M | 0.02% | Add |
| BNY Mellon history | Q2 2026 | 744.07K | $30.53M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 696.27K | $28.57M | 0.01% | Reduce |
| Capital World Investors history | Q3 2023 | 1.28M | $27.80M | 0.01% | Hold |
| Citigroup Inc history | Q2 2026 | 643.01K | $26.38M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 632.97K | $25.97M | 0.00% | Reduce |
| Scopia Capital Management history | Q2 2025 | 1.65M | $24.39M | 2.98% | Reduce |
| Marshall Wace history | Q4 2025 | 647.55K | $23.23M | 0.02% | Reduce |
| PSP Investments history | Q2 2026 | 418.88K | $17.19M | 0.04% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 402.42K | $16.51M | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 337.63K | $13.85M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 312.00K | $12.80M | 0.01% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 269.60K | $11.34M | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 266.36K | $10.93M | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 262.34K | $10.76M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 236.03K | $9.68M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 213.85K | $8.77M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 184.08K | $7.55M | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 144.37K | $5.92M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 83.70K | $3.43M | 0.00% | Reduce |
| Bridgewater Associates history | Q2 2026 | 68.18K | $2.80M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 45.58K | $1.87M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 41.66K | $1.71M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 49.45K | $1.51M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 28.55K | $1.17M | 0.00% | Add |
| CPP Investments history | Q4 2025 | 30.00K | $1.08M | 0.00% | New |
| UBS Group AG history | Q2 2026 | 20.00K | $820.60K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 16.81K | $689.72K | 0.00% | Add |
| Fidelity International (FIL) history | Q2 2023 | 18.44K | $427.02K | 0.00% | New |
| Amundi US history | Q2 2026 | 9.65K | $395.82K | 0.00% | New |
| Royce & Associates history | Q1 2026 | 9.90K | $301.75K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 955.11K | $39.19K | 0.00% | Add |
| Lazard Asset Management history | Q1 2025 | 339 | $3 | 0.00% | Reduce |